LUPIN
Lupin Limited
Healthcare · ₹1,14,441 Cr market cap
An innovation-led pharmaceutical company headquartered in Mumbai, Lupin develops and commercializes a broad range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients. The company operates as a transnational enterprise, serving customers across more than 100 markets including the United States, India, South Africa, Asia Pacific, Latin America, Europe, and the Middle East regions.
2
Tracked investors holding
0
Tracked moves
₹2,503
Share price
Top investors holding Lupin Limited
L
2.79%
1.30%